Significantly Enriched Pathways. حسب Jiyong Zhang (2498740)

الموضوعات:

Ether Cleavage Decreases the Ion Exchange Capacity of Anion Exchange Membranes حسب Shakkira Erimban (6882539)

Ether Cleavage Decreases the Ion Exchange Capacity of Anion Exchange Membranes حسب Shakkira Erimban (6882539)

<i>shk-1</i> mutants display decreased glycogen storage. حسب Longjun Pu (20685717)

Irradiation effect on <i>D. melanogaster</i> male sterility. GLM model values are shown. Values in boldface indicate significant differences (p < 0.05). حسب Flavia Cerasti (21655934)

الموضوعات:

TSLPR deficient mice show decreased AHR upon HDM exposure. حسب Latifa Koussih (326043)

HPD 1466 decreases empty capsid accumulation in cells replicating HBV. حسب Daniel P. Bradley (10306893)

RTL8 incorporates into PEG10 VLPs and decreases the efficiency of release. حسب Will Campodonico (20485651)

Characteristics of patients who decreased their screen time by more than 60 minutes after the challenge. حسب Annaëlle Le Steunf (19838110)

Decreasing oxygen saturation with corresponding levels of NLR and D-dimer for understanding the interplay of inflammation. حسب Narendran Gopalan (110148)

Infection of humanized mice resulted in decrease in pathogenicity in HTLV-1-CTCF infected mice. حسب Ancy Joseph (5634794)

iKIR score decreases protection associated with protective class II genotypes in T1D. حسب Laura Mora-Bitria (20477525)

Prenatal alcohol exposure (PAE) decreases brain and body weights at E14 and P0. حسب Danielle Sambo (6077924)

The reduced virulence of Δalta1 mutants is not primarily due to a decrease in growth. حسب Shuhuan Zhang (748003)

The ATR-CHK1 inhibitor AZD6738 decreases HBV cccDNA level. حسب Kaitao Zhao (3617825)

Composition of different formulations with their responses in I optimal design for optimization of Axitinib loaded Spanlastics. حسب Randa Mohammed Zaki (21637175)

الموضوعات:

The composition and validation of the optimized formula with its predicted responses according to I Optimal Design. حسب Randa Mohammed Zaki (21637175)

الموضوعات:

I Optimal design for optimization of Axitinib loaded Spanlastics. حسب Randa Mohammed Zaki (21637175)

الموضوعات:

ANOVA for I optimal design of Axitinib loaded Spanlastics. حسب Randa Mohammed Zaki (21637175)

الموضوعات:

The kinetic release data of the optimized formula compared to drug suspension. حسب Randa Mohammed Zaki (21637175)

الموضوعات: